Current Pharmaceutical Design

Table of Contents Alert
To view papers online ahead of print schedule–Click Below
May 8, 2013
Current Pharmaceutical Design ISSN: 1381-6128 Volume 19, Number 21, 2013 [Should you not want to receive any further emails regarding TOC Alerting Service, then please click here to discontinue services. Please also provide any other email address that you might be using for complete discontinuation of services] Table of Contents  (For viewing abstracts please visit this link) Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update) Pp. 3749-3752 Alberico L. Catapano, Moses S. Elisaf, Matilda Florentin, Dimitri P. Mikhailidis and Michael S. Kostapanos [Download PDF] Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin- Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker? Pp. 3753-3765 Nicoletta Riva and Gregory Y.H. Lip [Abstract] [Purchase Article] Hydrochlorothiazide vs. Chlorthalidone as the Optimal Diuretic for the Management of Hypertension Pp. 3766-3772 Konstantinos Tziomalos, Vassilios G. Athyros, Dimitri P. Mikhailidis and andAsterios Karagiannis [Abstract] [Purchase Article] How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes? Pp. 3773-3787 Vasilios Tsimihodimos, Matilda Florentin and Moses S. Elisaf [Abstract] [Purchase Article] Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy? Pp. 3788-3794 Haralampos Milionis and Patrik Michel [Abstract] [Purchase Article] Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring Pp. 3795-3815 Udaya S. Tantry and Paul A. Gurbel [Abstract] [Purchase Article] Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists Pp. 3816-3826 Dariusz Kozlowski, Szymon Budrejko, Grzegorz Raczak, Jacek Rysz and Maciej Banach [Abstract] [Purchase Article] Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives Pp. 3827-3840 Elisavet Moutzouri, Vasilis Tsimihodimos and Alexandros D. Tselepis [Abstract] [Purchase Article] Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality Pp. 3841-3857 Angela Pirillo, Giuseppe Danilo Norata and Alberico Luigi Catapano [Abstract] [Purchase Article] Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia? Pp. 3858-3868 Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis and Maciej Banach [Abstract] [Purchase Article] PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders? Pp. 3869-3877 Maciej Banach, Manfredi Rizzo, Milan Obradovic, Giuseppe Montalto, Jacek Rysz, Dimitri P. Mikhailidis and Esma R. Isenovic [Abstract] [Purchase Article] A Rational Approach to Identify Inhibitors of Mycobacterium tuberculosis Enoyl Acyl Carrier Protein Reductase Pp. 3878-3883 Mahesh T Chhabria, Kailash B Parmar and Pathik S Brahmkshatriya [Abstract] [Purchase Article] Current Developments of Coumarin Compounds in Medicinal Chemistry Pp. 3884-3930 Xin-Mei Peng, Guri L.V. Damu and Cheng- He Zhou [Abstract] [Purchase Article]   Reprints of above articles available ON ORDER. Please pass this alert to the relevant authority who may want to order reprints at: reprints@benthamscience.org. Thank you Copyright © 2013 Bentham Science Publishers